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Abstract  
Background: Previous studies of posttraumatic stress disorder (PTSD) were mainly 
of patients at a chronic stage, focussing on brain regions outside the amygdala. The 
goals of this study were to investigate the early biochemical and structural changes of 
anterior cingulate cortex (ACC) and amygdala in patients with PTSD and to explore 
their relationships. Methods: Seventy-eight PTSD subjects and 71 non-PTSD control 
subjects were enrolled, all of whom had suffered the same earthquake less than one year 
before. Single-voxel proton magnetic resonance spectroscopy (1H-MRS) was 
performed and absolute metabolite concentrations in ACC and bilateral amygdalae 
were estimated with LCModel. Bilateral amygdalae were manually outlined and their 
volumes were calculated and corrected for the total intracranial volume. Results: The 
PTSD group showed significantly increased N-acetylaspartate (NAA) concentrations 
in the ACC, increased creatine (Cr) concentrations in the left amygdala, and increased 
myo-inositol (mI) concentrations in the right amygdala, compared to non-PTSD 
controls. The NAA concentrations in ACC were negatively correlated with the time 
since trauma. The PTSD group showed significantly decreased volume of bilateral 
amygdalae compared to non-PTSD controls, but amygdala volumes were not correlated 
with metabolite concentrations. Conclusions: This concurrent increase in some 
metabolite concentrations and decrease of amygdala volumes may represent a pattern 
of biochemical and morphological changes in recent-onset PTSD which is different 
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from that reported in chronic PTSD. 
Keywords: posttraumatic stress disorder, brain, magnetic resonance, spectroscopy, 
metabolites, morphometry 
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Introduction  
Posttraumatic stress disorder (PTSD) is a psychiatric disorder affecting people who 
are exposed to extraordinary distress events, whose main symptoms are reliving the 
traumatic event, avoiding trauma-related cues, negative alterations in thinking and 
feeling, and hyperarousal (1). The lifetime prevalence of PTSD is reported as 2% to 9% 
(2). Patients with PTSD are at increased risk of suicide, which is as high as 13% in one 
study of 431 veterans (3, 4). 
A growing number of neuroimaging studies have investigated potential 
neurocircuitry models of PTSD (5). The two main hypotheses have been hyper-
responsivity of the amygdala to threat-related stimuli, and deficient regulation by the 
ACC (6-9). Functional studies have supported the two hypotheses that hyper-activation 
of the amygdala contributes to the exaggerated fear response and persistence of 
traumatic memories, and that hypo-activation of ACC is important in the exaggerated 
threat detection and fear learning in PTSD (7, 9). In addition, resting-state connectivity 
studies have shown increased coupling within the salience network, including the 
amygdala and the ACC, which is associated with attention to external stimuli (10). 
Proton magnetic resonance spectroscopy (1H-MRS), a non-invasive method to 
measure localized brain metabolite concentrations, offers a way to probe cellular 
properties and metabolism. A number of MRS studies have reported abnormal 
metabolite levels in several brain regions in adult PTSD, but their findings have been 
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inconsistent (11). In the ACC there have been reports of decreased N-acetylaspartate 
(NAA) (12-15) and conversely of no abnormality of NAA (16-18). Creatine (Cr) has 
often been used as an internal reference for estimating the absolute concentrations of 
other metabolites in MRS studies, based on the assumption that its own concentration 
in relatively constant (19). However, decreased absolute Cr concentrations have been 
reported in the hippocampus of PTSD patients (20). Furthermore, there have been no 
published studies focusing on metabolic changes in the amygdala in adult PTSD 
patients, although its role in the regulation of emotion has been widely acknowledged.  
There are similar inconsistencies among reports of structural imaging studies. In 
some the amygdala volume is decreased in PTSD patients compared to controls (21-
23), and negatively associated with the severity of PTSD (21, 22); other studies have 
found no significant inter-group differences (24-26).  
Most PTSD patients are studied a long time after the precipitating trauma, so early 
changes have not been well explored. Vietnam combat veterans with long disease 
durations have been widely studied by MRS (14, 27, 28). In other studies of PTSD 
patients trauma types were mixed (29, 30). Control subjects also differ between studies: 
in some, healthy subjects (13), but in others, non-PTSD participants with trauma 
experience (18), or mixed (16).  
In the present study, we explored the structural and neurobiochemical changes of the 
ACC and the amygdalae in patients with PTSD who survived an extraordinary 
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earthquake several months before. The control subjects came from the same region and 
were exposed to the same traumatic event. We used absolute metabolite quantification 
and manual volumetric methodology to measure metabolite concentrations and 
amygdala volumes, respectively. We aimed to define abnormalities in the ACC and the 
amygdalae in recent-onset, medication-free patients with PTSD, and to compare these 
with reported abnormalities in the more often studied condition of chronic PTSD. 
Methods and Materials  
Subjects  
All participants in this study had suffered from a devastating earthquake in May 2008 
in Wenchuan County, Sichuan Province, the People's Republic of China. The 
prevalence of suspected PTSD in some stricken areas was as high as 46% (31). In all 
184 adult survivors were recruited between January 2009 and August 2009, and all of 
them completed MRI and MRS examinations. The PTSD Checklist and the Clinician-
Administered PTSD Scale (CAPS) were applied to assess traumatic severity and PTSD 
symptoms of the subjects (32, 33). The participants were interviewed by an experienced 
psychiatrist and classified based on the diagnostic criteria of the DSM-IV (Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition)(34). Those who met the 
criteria for PTSD related to this trauma were classified as the PTSD patient group, while 
those who did not meet the criteria were enrolled as the control group (non-PTSD). 
Exclusion criteria for all subjects were as follows: other Axis I psychiatric diagnosis; 
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medicine and/or alcohol abuse; any significant medical or neurological conditions or a 
history of head injury; left-handedness; any contraindication to MR imaging; age less 
than 18 or more than 65 years. Finally 78 drug-naive first-episode PTSD patients (20 
males, 58 females, mean age 43.0±10.4 years) and 71 control subjects (23 males, 48 
females, mean age 43.4±9.9 years) were included in the study. All participants were 
right-handed. Table 1 summarises the detailed demographic and clinical characteristics 
of these subjects. This study was approved by the Research Ethics Committee of the 
West China Hospital of Sichuan University. All participants gave written informed 
consent. 
Magnetic Resonance Imaging Spectroscopy  
All MR examinations were performed using a 3.0 T MR imaging system (Excite; GE 
Healthcare, Milwaukee, Wis) and an eight-channel phase-array head coil. All subjects 
underwent routine brain MR imaging (MRI) examinations, firmly padding the head to 
minimize motion. High-resolution T1 weighted images (3-dimensional spoiled gradient 
recall sequence) were acquired and reconstructed for localization of the MR 
spectroscopy voxels. The sequence parameters were as follows: repetition time (TR) 
8.5 ms, echo time (TE) 3.4 ms; field of vie 24cm×24cm; flip angle 12°; 156 axial slices; 
thickness 1.0 mm; matrix size 512×512. Single voxel 1H-MRS was performed using 
PRESS (Point Resolved Spectroscopy) sequence, with parameters as follows: TR 
2000ms, TE 30ms, spectral bandwidth 1200Hz, 1024 data points, 128 signals average. 
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Volumes of interest (VOIs) were placed in the ACC and bilateral amygdalae (example 
spectra are shown in Fig 1). The voxel size varied with the shape and size of the ROI. 
To avoid contamination from neighboring cerebrospinal fluid or scalp fat, 6 pre-
saturation bands for outer volume suppression were placed around the voxel. The built-
in spectral GE software automatically accomplished field shimming and water 
suppression, and data acquisition started only when the prescan showed that the full 
width at half maximum (FWHM) of the water peak was < 7Hz and water suppression 
was > 95%.  
MRS Data Post-processing  
MRS data were excluded as of low quality if they met one of the following criteria: 
a. signal to noise ratio (SNR) for Cr < 15, and FWHM > 0.08ppm. The MRS raw data 
were exported and analysed u LCModel (Version 6.3-1H) using a basis set yielded by 
the same sequence and the same parameters (35). Eddy-current correction and water 
reference scaling were performed to improve spectral quality. Metabolites selected for 
further analysis were: NAA, glutamine plus glutamate (Glx), creatine plus 
phosphocreatine (Cr), choline (Cho), and myo-inositol (mI). Only values with a fitting 
error < 15% were accepted for further statistical analysis.  
Measurement of Amygdala Volume  
Volume of bilateral amygdalae was measured by manual tracing on 3-dimensional 
T1-weighted MR images (1 mm section thickness) which were reconstructed from axial 
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T1-weighted MR images. To visualize the amygdalae and separate them from nearby 
brain structures, oblique coronal images were reconstructed perpendicular to the long 
axis of the hippocampus (36). The positional normalizations were performed using 
MATLAB R2012b. The amygdala was manually segmented using ITK-SNAP 
(http://www.itksnap.org/pmwiki/pmwiki.php, version 3.6.0) (37), an open-source 
multi-platform software for tissue segmentation. Two radiologists blinded to the group 
membership traced the amygdala volumes independently. Inter-operator reliability was 
confirmed by correlation coefficients for the left and the right amygdala of 0.909 and 
0.912, respectively.  
The anatomic boundaries of the amygdala were defined in oblique coronal images 
and set as follows (38) (Fig 2):  
• The anterior border was taken where the lateral sulcus closes to form the 
entorhinal sulcus.  
• The posterior border was defined as the point where grey matter first starts to 
appear superior to the alveus of the hippocampus and lateral to the 
hippocampus head; if the alveus was not visible, the inferior horn of lateral 
ventricle was used as a border.  
• The medial border included the uncus, while entorhinal cortex inferior to the 
uncal notch was excluded; if the uncal notch was not clear, a line was drawn 
from the most inferior point to the most medial aspect of the amygdala.  
 10 Xiaorui Su  
 
• The lateral border was defined by the inferior horn of the lateral ventricle, or 
adjacent white matter. 
• For the superior border, the anterior part was defined by a straight line 
laterally from the entorhinal sulcus to the fundus of the inferior portion of the 
circular sulcus of the insular cortex; the posterior part was defined by a 
straight line laterally from the superolateral aspect of optic tract to the fundus 
of circular sulcus of insular cortex;  
• The inferior border was defined by the uncal recess of lateral ventricle, such 
as the temporal horn, or by white matter.  
The outline of the amygdala in each slice was traced with a manually driven mouse 
cursor. Delineated voxels were automatically summed by the software to calculate 
overall amygdala volumes.  
Amygdala volumes were adjusted for total intracranial volume (TIV) (39, 40), which 
corrects for variation in head size (41, 42). Rapid automatic estimation of TIV was 
performed using the FreeSurfer image analysis suite and its library tool ‘recon-all’ 
(http://surfer.nmr.mgh.harvard.edu/) (23). The measured amygdalae volumes were 
normalized according to the following equation (40):  
Volumei, adjusted = Volume i, observed - B(TCVi –  ),  
where TCVi is the individual’s total intracranial volume,  is the overall average 
total intracranial volume in the control group, and B is the slope of the regression line 
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of amygdala volume against total intracranial volume. 
Statistical Analysis  
All demographic characteristics, clinical, metabolite and volumetric data were tested 
for normality and homogeneity of variance. The independent samples t-test was used 
to analyse differences in quantitative variables between the two groups. First, 
demographic and clinical characteristics of PTSD and non-PTSD groups were 
compared. Then metabolite concentrations of all regions and volumes of bilateral 
amygdalae were compared between the PTSD and non-PTSD groups. Metabolites 
which demonstrated significant intergroup difference were further examined for their 
correlations with clinical variables or volume within the PTSD group using Pearson’s 
correlation coefficient. For the multiple comparisons of metabolite concentrations and 
volumes, alpha levels were corrected using the FDR (False Discovery Rate) procedure 
(43). The significant level after correction (Padj) was set at 0.05. Effect sizes were 
calculated via Cohen's d (0.2 = small, 0.5 = medium, 0.8 = large) (44). Values were 
expressed as mean±SD. 
Results  
Demographic and Clinical Variables 
The PTSD and non-PTSD groups showed no significant differences in age, sex, 
education, or time since trauma (P >0.05). Both groups showed a similar predominance 
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of female subjects. As expected PTSD patients scored significantly higher on PCL and 
total CAPS scores (P<0.05) (Table 1).  
Metabolite Concentrations and Brain Volumes  
Results of statistical analysis are given in Table 2. In the ACC, PTSD patients had 
significantly increased NAA concentrations compared to non-PTSD controls (t =3.63, 
Padj <0.001, d =0.76), but other metabolites (mI, Cr, Cho and Glx) showed no significant 
intergroup difference (Padj≥0.05). For amygdalae, PTSD patients had significantly 
increased Cr concentration in the left amygdala and increased mI concentrations in the 
right amygdala compared to controls (Cr of left amygdala: t=3.53, Padj=0.004, d=0.89; 
mI of right amygdala: t=2.58, Padj=0.045, d=0.91) (Fig 3).  
Both the left and right amygdalae volumes of PTSD patients were significantly 
decreased compared with controls (left: t= -3.44, Padj =0.004, d = -0.58; right: t= -4.32, 
Padj<0.001, d = -0.73) as was, total amygdala volume (t= -4.51, Padj<0.001, d = -0.76). 
Effect sizes for significant inter-group differences of metabolites and volumes were 
medium or strong (Cohen's d =0.58–0.91).  
Correlations of metabolite concentrations 
Table 3 shows the correlations between the metabolite concentrations and other 
variables in PTSD subjects. NAA concentrations in the ACC were negatively correlated 
with the time since trauma (r =-0.30, P=0.02) (Fig 4). No significant correlations were 
 13 Xiaorui Su  
 
found between clinical variables or amygdala volume and either Cr concentrations of 
left amygdala or mI concentrations of right amygdala (Cr concentrations with left 
amygdala volume: r =0.002; mI concentrations with right amygdala volume: r =-0.009; 
P>0.05).  
Discussion  
  Compared with non-PTSD controls, the PTSD patients showed 4 significant 
abnormalities: 1) NAA concentrations were significantly increased in the ACC and 
negatively correlated with the time since trauma; 2) Cr concentrations were 
significantly increased in the left amygdala; 3) mI concentrations were significantly 
increased in the right amygdala; and 4) volumes of bilateral amygdalae were decreased. 
To our knowledge, this is the first reported MRS study of the amygdala as well as the 
first to report increased NAA in adult patients with PTSD. We now discuss the possible 
pathophysiological significance of these abnormalities. 
Metabolic abnormalities in the ACC 
In contrast to our finding of increased NAA concentration in the ACC, two previous 
studies of PTSD have reported decreased NAA in the ACC (13, 45): Ham et al (13) in 
PTSD patients examined 15.0 ± 1.1 months after a fire accident, and Meyerhoff et al 
(45) in PTSD patients exposed to trauma events about 10 years previously. In the 
present study the mean time was shorter, only 10.5±1.8 months. These findings 
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suggested that PTSD patients may demonstrate different metabolic changes at different 
stages. In support of this, we found that the NAA concentrations in the ACC were 
negatively correlated with time since trauma, suggesting that NAA might be on track 
to decrease below normal when the disease progresses to the chronic stage. Furthermore, 
similar metabolic changes have been reported in other psychiatric disorders. A recent 
study exploring prefrontal metabolite concentrations at different stages of psychotic 
disorders found that NAA decreased during illness progression (46). Similarly, a 
longitudinal analysis found that depressed patients presented a progressive decrease of 
NAA/Cr ratio (47). A study of schizophrenia reported decreased frontal NAA in patients 
with chronic schizophrenia, but not in first-episode schizophrenia (48). In the light of 
these reports we suggest that our results might reflect the early changes of PTSD, while 
other reports (13, 45) may reflect later changes. Although there is no clear 
pathophysiological explanation for the increased NAA in PTSD, a similar finding has 
been reported in social anxiety disorder, where it was speculated that increased NAA in 
the ACC may be associated with increased activity in the emotional processing network 
(49). 
Metabolic and volume abnormalities in the amygdalae 
In our study PTSD patients had a significantly increased Cr concentration in the left 
amygdala, while Cr in the right amygdala demonstrated a trend towards increase which 
did not reach statistical significance (P and Padj were 0.06 and 0.14, respectively). 
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Although Cr concentration has generally been believed to be unaffected in 
neurodegenerative processes, some studies have demonstrated otherwise (20, 50-52). 
Decreased Cr concentrations have been reported in the right hippocampus of PTSD 
patients (20) and in the ACC of depressive patients (51). Of more direct relevance to 
our study, increased Cr concentration has been reported in the left amygdala in patients 
with borderline personality disorder (50), and in the frontal brain in depressed patients 
(52).  
Given the involvement of Cr in cellular energy metabolism (53), it is tempting to 
speculate that the increased Cr concentrations in the amygdala reflect more ‘active’ 
local energy metabolism (in some sense) in recent-onset PTSD, perhaps as part of an 
attempted protective response to trauma (54).  
However, another possibility is glial proliferation. Glial cells are stress responsive, 
and glial abnormalities reportedly play a role in the pathophysiology of mood disorders 
(55). In a rodent model, acute stress can modulate glial cell activity (56). mI, being 
primarily located in glial cells, is a putative glial cell marker (57). An MRS study of 
myotonic dystrophy reported increases in both Cr and mI, and suggested that both might 
be explained by increased glial content (58). We observed a significant increase in mI, 
but only in the right amygdala. An increased mI/Cr in ACC has been reported 
previously in PTSD, and taken to be associated with glial proliferation (16). It is 
tempting to suggest that reactive proliferation of glial cells in response to trauma 
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accounts for both the mI and Cr abnormalities in early-stage PTSD subjects. Against 
this, our PTSD patients showed no significant change in mI concentration in the left 
amygdala, nor in Cr concentration in the right amygdala. This may reflect some 
functional difference or asymmetry between the left and the right amygdala, which are 
known to respond differently to emotional stimuli (59). MRS studies of other 
psychiatric diseases have also reported differing metabolite abnormalities in the two 
amygdalae (50).  
We also demonstrated volume decrease of bilateral amygdalae in the PTSD patients. 
Previous studies of amygdala volume in PTSD have been inconsistent (21-24, 36, 60, 
61). Some studies have reported normal or increased amygdala volumes (24, 36, 60), 
although patients in these studies tend to have a long illness duration , and one study 
was complicated by a high level of comorbidity with MDD (36). Other studies of PTSD 
have reported decreased amygdala volume compared with controls (21-23, 61), as we 
found. As to the mechanism of this structural abnormality, in a rodent model acute stress 
led to hypotrophy in basolateral amygdala (62), while chronic stress caused extensive 
spinogenesis and persistent dendritic elongation and induced basolateral amygdala 
hypertrophy (63, 64). Thus the acute stress might account for the volume decrease in 
amygdala in our patients, who were not comorbid with MDD, and who were examined 
at an early stage of their disease.  
A reactive astrogliosis can be viewed as a defensive reaction against acute stress (65). 
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We tentatively suggested above that the neurochemical abnormalities we observed in 
the amygdala might be a consequence of such a gliosis, although the findings do differ 
between the two sides. Acute stress can lead to basolateral amygdala hypotrophy (62), 
which makes this an attractive causal explanation for the decrease we observed in 
bilateral amygdala volume. Brain atrophy and gliosis co-exist in many neurological 
diseases, such as frontal lobe dementia (66) and traumatic brain injury (67). 
Furthermore, coexistent hippocampal atrophy and glial proliferation has previously 
been reported in PTSD (20). How acute stress leads to gliosis and brain atrophy remains 
unclear, and further studies are needed to clarify it. 
Limitations 
There are two main limitations to our study. Firstly, the volume measurement was 
performed only on the bilateral amygdalae. Manual boundaries the ACC have no 
standard definition (68, 69), which makes it very difficult to estimate accurate volumes. 
Secondly, the present study only examined in the early stage of PTSD. Chronic changes 
in these patients were not explored because they received psychotherapy and 
medication (as clinically indicated) after the examination. Longitudinal studies are 
needed to explore the metabolic and structural changes of PTSD at different stages. 
In conclusion, this study of recent-onset PTSD patients showed significantly 
increased NAA in ACC, increased Cr in left amygdala and increased mI in right 
amygdala, along with decreased volume decrease in bilateral amygdalae. This appears 
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to be a different pattern of biochemical and morphological changes to that reported in 
chronic PTSD. These findings confirm that the ACC and amygdala participate in the 
pathophysiology of PTSD, although elucidating the mechanisms will require further 
research. 
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FIGURES AND TABLES 
Table 1. Clinical and Demographic Data in PTSD Patients and Control Subjects 
 (mean ± SD) 
Group 
and analysis 
Characteristic 
Age
（years) 
Male/ 
female 
Years of 
education 
 
Months 
since trauma 
CAPS PCL 
PTSD 43.0±10.4 20/58 7.0±3.3 10.6±2.4 56.3±15.7 48.8±13.0 
Non-
PTSD 
43.4±9.9 23/48 7.0±3.4 11.3±2.0 21.5±11.0 27.8±7.2 
P value 0.78 0.36 0.94 0.14 0.02 0.00 
Non-PTSD, control subjects; PTSD, posttraumatic stress disorder; CAPS: Clinician-
Administered PTSD Scale; PCL, PTSD Checklist 
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Table 2. Volumetric and Metabolic Measurements in the ACC and Bilateral Amygdalae in PTSD Patients and Control Subjects (mean ± SD) 
 
VOI Group Metabolite levels（mmol/kg wet weight） Volume（cm3） 
mI NAA Cho Cr Glx 
ACC PTSD 8.00±1.51 9.12±1.29 2.38±0.47 8.30±1.12 15.79±2.24 ND 
 Non-PTSD 7.05±1.17 8.35±1.22 2.52±0.37 8.19±1.33 16.32±3.02 ND 
 P (Padj) 0.02 (0.05) <0.001 0.25 (0.30) 0.23 (0.30) 0.40 (0.45) - 
 Cohen's d 0.70 0.76 -0.24 0.23 -0.19 - 
L-AM PTSD 10.07±1.83 9.79±1.63 3.16±0.57 9.03±1.56 18.29±2.61 1.27±.0.13 
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 Non-PTSD 9.41±1.14 9.19±1.40 2.89±0.59 7.82±1.14 16.92±3.17 1.35±0.14 
 P (Padj) 0.19 (0.29) 0.17 (0.29) 0.07 (0.14) 
0.001 
(0.004) 
0.18 (0.29) 0.001 (0.004 ) 
 Cohen's d 0.43 0.39 0.47 0.89 0.47 -0.58 
R-AM PTSD 10.38±2.10 9.15±1.55 2.98±0.43 8.65±1.65 16.89±2.44 1.31±0.11 
 Non-PTSD 8.60±1.81 9.35±2.32 2.82±0.50 7.89±1.20 17.04±3.35 1.40±0.14 
 P (Padj) 0.015 (0.045) 0.74 (0.78) 0.24 (0.30) 0.06 (0.14) 0.90 (0.90) 0.00 
 Cohen's d 0.91 -0.10 0.33 0.53 -0.05 -0.73 
ACC, anterior cingulate cortex; L-AM, left amygdala; R-AM, right amygdala; mI, myo-inositol; NAA, N-acetylaspartate; Cho, choline; Cr, 
creatine + phosphocreatine; Glx, glutamate + glutamine; Padj, adjusted P value; ND, not done. 
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Table 3. Correlation of Clinical Variables and Metabolite Levels Found to Differ 
Between Groups after Adjusting Alpha Levels 
Clinical 
variables 
Metabolites and volumes differing between groups 
  
CAPS Age (years) 
Time since trauma 
(months ) 
NAA in 
ACC 
r 0.25 -0.08 -0.30 
p 0.08 0.54 0.02* 
Cr in L-
AM 
r 0.07 0.02 0.92 
p 0.70 0.18 0.14 
mI in R-
AM 
r 0.39 0.52 -0.28 
p 0.29 0.40 0.31 
*P<0.05 
ACC: anterior cingulate cortex; L-AM, left amygdala; R-AM, right amygdala; 
CAPS: Clinician-Administered PTSD Checklist 
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Figure 1. Results of analysis of spectral data in a single subject in three brain regions: 
A, anterior cingulate cortex; B, left amygdala; C, right amygdala. The data are fitted 
using the LCModel, from which absolute metabolite concentrations are calculated 
using the unsuppressed water signal as an internal reference. 
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Figure 2. The manual segmentation of bilateral amygdalae on 3-dimensional T1-
weighted MR images. A, cross section; B, sagittal section; C, coronal section. 
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Figure 3. Metabolite levels in the ACC (A) and bilateral amygdalae (B, C) in PTSD 
patients and control subjects. Error bars indicate standard deviation. The PTSD group 
showed significantly increased NAA levels in the ACC, increased Cr levels in the left 
amygdala, and increased mI levels in the right amygdala.  
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Figure 4. The correlation of NAA concentrations in the ACC of PTSD patients with 
the time since trauma (r= -0.30, P=0.02)  
 
